Table 1 Baseline characteristics of patients with intracranial atherosclerotic stenosis (ICAS)-related occlusions and endovascular treatments

 Age, years

66.3 ± 11.7

63.9 ± 15.2

0.348

 Sex, men

39 (62.9)

31 (63.3)

> 0.999

 Hypertension

38 (61.3)

33 (67.3)

0.645

 Diabetes mellitus

20 (32.3)

14 (28.6)

0.833

 Dyslipidemia

23 (37.1)

12 (24.5)

0.225

 Atrial fibrillation

14 (22.6)

10 (20.4)

0.965

 Smoker

26 (41.9)

13 (25.5)

0.103

 Antiplatelets

11 (17.7)

7 (14.3)

0.817

 Anticoagulants

2 (3.2)

4 (8.2)

0.403

Initial occlusion site

0.078

 Internal carotid artery

12 (19.4)

2 (4.1)

 Middle cerebral artery, M1

36 (58.1)

36 (73.5)

 Middle cerebral artery, M2

2 (3.2)

1 (2.0)

 Vertebral artery

2 (3.2)

4 (8.2)

 Basilar artery

10 (16.1)

6 (12.2)

Initial NIHSS score

16.5 (11–22)

15 (12–19)

0.340

ASPECTS score^a

7.5 (5–9)

7 (6–8)

0.625

 Hemoglobin, g/dL

14.0 ± 1.8

13.9 ± 2.0

0.764

 White blood cells, ×10⁹/L

9.6 ± 3.6

11.5 ± 5.6

0.047

 Platelets, ×10⁹/L

240 ± 77

239 ± 59

0.928

 Glucose, mmol/L

8.2 ± 3.3

8.4 ± 3.3

0.813

Intravenous tPA

27 (43.5)

23 (46.9)

0.869

Use of balloon guide catheter

36 (58.1)

26 (53.1)

0.738

Onset to door time, min

208 (111–387)

172 (105–560)

0.801

Door to puncture time, min

97.5 (77–127)

111 (92–138)

0.106

 Solitaire

41 (83.7)

 Trevo

8 (16.3)

 Penumbra, 1st generation

45 (72.6)

 Penumbra, 2nd generation

17 (27.4)